These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25924599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
    Huang L, Miao H, Sun Y, Meng F, Li X.
    Eur J Med Chem; 2014 Nov 24; 87():429-39. PubMed ID: 25282266
    [Abstract] [Full Text] [Related]

  • 8. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
    Di Pietro O, Pérez-Areales FJ, Juárez-Jiménez J, Espargaró A, Clos MV, Pérez B, Lavilla R, Sabaté R, Luque FJ, Muñoz-Torrero D.
    Eur J Med Chem; 2014 Sep 12; 84():107-17. PubMed ID: 25016233
    [Abstract] [Full Text] [Related]

  • 9. Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease.
    Tonelli M, Catto M, Sabaté R, Francesconi V, Laurini E, Pricl S, Pisani L, Miniero DV, Liuzzi GM, Gatta E, Relini A, Gavín R, Del Rio JA, Sparatore F, Carotti A.
    Eur J Med Chem; 2023 Mar 15; 250():115169. PubMed ID: 36753881
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
    Więckowska A, Więckowski K, Bajda M, Brus B, Sałat K, Czerwińska P, Gobec S, Filipek B, Malawska B.
    Bioorg Med Chem; 2015 May 15; 23(10):2445-57. PubMed ID: 25868744
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W, Mohamed T, Sit VM, Vasefi MS, Beazely MA, Rao PP.
    Chem Biol Drug Des; 2016 Nov 15; 88(5):710-723. PubMed ID: 27282589
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Bajda M, Jończyk J, Malawska B, Czarnecka K, Girek M, Olszewska P, Sikora J, Mikiciuk-Olasik E, Skibiński R, Gumieniczek A, Szymański P.
    Bioorg Med Chem; 2015 Sep 01; 23(17):5610-8. PubMed ID: 26242241
    [Abstract] [Full Text] [Related]

  • 13. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y, Qiang X, Li Y, Yang X, Luo L, Xiao G, Cao Z, Tan Z, Deng Y.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2035-9. PubMed ID: 26947607
    [Abstract] [Full Text] [Related]

  • 14. Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease.
    Rosales Hernández MC, Olvera-Valdez M, Velazquez Toledano J, Mendieta Wejebe JE, Fragoso Morales LG, Cruz A.
    Molecules; 2024 Oct 09; 29(19):. PubMed ID: 39407708
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Human Cholinesterases and in vitro β-Amyloid Aggregation by Rationally Designed Peptides.
    Sanchis I, Spinelli R, Dias J, Brazzolotto X, Rietmann Á, Aimaretti F, Siano ÁS.
    ChemMedChem; 2023 Jun 15; 18(12):e202200691. PubMed ID: 36995341
    [Abstract] [Full Text] [Related]

  • 16. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.
    Bioorg Med Chem; 2012 Nov 15; 20(22):6669-79. PubMed ID: 23062825
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z, Pan W, Wang K, Ma Q, Yu L, Yang Y, Bai P, Leng C, Xu Q, Li X, Tan Z, Liu W.
    Eur J Med Chem; 2017 Apr 21; 130():379-392. PubMed ID: 28279845
    [Abstract] [Full Text] [Related]

  • 18. Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.
    Prati F, Bergamini C, Fato R, Soukup O, Korabecny J, Andrisano V, Bartolini M, Bolognesi ML.
    ChemMedChem; 2016 Jun 20; 11(12):1284-95. PubMed ID: 26880501
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta.
    Hebda M, Bajda M, Więckowska A, Szałaj N, Pasieka A, Panek D, Godyń J, Wichur T, Knez D, Gobec S, Malawska B.
    Molecules; 2016 Mar 26; 21(4):410. PubMed ID: 27023510
    [Abstract] [Full Text] [Related]

  • 20. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J, Iorga BI, Guillou C.
    Eur J Med Chem; 2011 Jun 26; 46(6):2193-205. PubMed ID: 21435752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.